Health Medical Breakthroughs Treatment

Artery Disease Treatment Research: New Drug Could Help Prevent Artery Disease in High-risk Patients

Posted on Posted in Cardiovascular Disease News, Coronary Artery Disease

(SOURCE: UNIVERSITY OF MISSOURI-COLUMBIA) – A recent study by researchers at the University of Missouri School of Medicine has shown that a protein inhibitor drug prevents these blockages, and could be a new therapeutic approach to prevent heart attack, stroke and other diseases caused by blocked blood vessels. According to the American Heart Association, approximately 2,200 Americans […]

Health Medical Breakthroughs Treatment

Malignant Rhabdoid Tumor Research News: Loss of key protein unleashes cascade that culminates in rhabdoid tumor formation

Posted on Posted in Cardiovascular Disease News, Malignant Rhabdoid Tumor News

(SOURCE: HARVARD MEDICAL SCHOOL) – Rhabdoid tumors are among the most recalcitrant childhood cancers, and scientists have long sought ways to understand what drives their resilience and makes them impervious to treatment. Now researchers from Harvard Medical School, St. Jude Children’s Research Hospital and elsewhere have uncovered a molecular chain of events that interferes with a key […]

Health Medical Breakthroughs Treatment

Statins Help Prevent Heart Attacks and Strokes in Adults with Cardiovascular Risk According to Trial Study

Posted on Posted in Brain Injury - Stroke News, Cardiovascular Disease News, Heart Disease News

(OREGON HEALTH & SCIENCE UNIVERSITY) According to a recent press release, cholesterol-lowering drugs help prevent heart attacks and strokes in adults with cardiovascular risk factors such as high cholesterol, high blood pressure, diabetes and smoking, but have not yet had a heart attack or stroke, according to a large-scale analysis of clinical trial data led […]

Health Medical Breakthroughs Treatment

Jardiance® (empagliflozin) Consistently Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Cardiovascular Disease in Trial

Posted on Posted in Cardiovascular Disease News, Diabetes News

(PR Newswire) According to a recent press release, new data presented at the American Heart Association Scientific Sessions 2016 showed that Jardiance® (empagliflozin) tablets consistently reduced the risk for cardiovascular death, regardless of the type of cardiovascular disease at baseline, compared with placebo when added to standard of care in adults with type 2 diabetes and […]

Health Medical Breakthroughs Treatment

Patients Taking Statins May Survive Longer Following Cardiac Arrest

Posted on Posted in Cardiovascular Disease News, Coronary Artery Disease, Heart Disease News

(AMERICAN HEART ASSOCIATION) According to a recent press release, patients who have been taking statins are likely to survive longer after a cardiac arrest than those who are not taking them, according to research from Taiwan researchers presented during the Resuscitation Science Symposium at the American Heart Association’s Scientific Sessions 2016.

Health Medical Breakthroughs Treatment

Study Finds Diet Rich in Whole Grains May Significantly Lower the Risk of Cardiovascular Disease

Posted on Posted in Cardiovascular Disease News, Heart Disease News, Nutrition News

(EurekAlert) According to an article recently published in EurekAlert, a team of researchers from Cleveland Clinic, working in collaboration with Nestlé Research Center, conducted one of the largest controlled studies of its kind on whole grains and concluded that a diet rich in whole grains may significantly lower the risk of cardiovascular disease in overweight […]

Health Medical Breakthroughs Treatment

Biomarkers May be Effective in Predicting Type 2 Diabetes Cardiovascular Risk

Posted on Posted in Cardiovascular Disease News, Diabetes News

(Diabetes.co.uk) According to new research from the Heart Outcomes Prevention Evaluation (HOPE) study, a panel of ten biomarkers including angiopoietin-like protein 2 and N-terminal pro-B-type natriuretic peptide could possibly be of research value to help identify type 2 diabetes patients with high cardiovascular risk when added to routine clinical risk factors.